JellyFil Official Website › Men's Vitality Guide
Men's Vitality GuideThe Men's Vitality Supplement Guide: Botanicals, Evidence And Blends
This aisle runs on about a dozen botanicals, and their evidence is unevenly distributed.
Two or three have randomised human trials at amounts measured in grams. Several have mechanism studies in cells and animals and nothing in people. Two have been tested properly and have largely not delivered. Almost all of them are sold inside proprietary blends, and this guide explains why that is and what it costs a reader.
Written about the category rather than about one product, so it stays useful against anything on the shelf.
What this category is actually made of
| Botanical or compound | What it is | Where the evidence sits |
|---|---|---|
| Maca (Lepidium meyenii) | A Peruvian root vegetable | Randomised human trials at 1.5 g to 3 g a day; suggestive rather than settled |
| Ashwagandha (Withania somnifera) | An Indian adaptogen | The largest randomised literature in the aisle, at 240 mg to 600 mg a day |
| Tribulus terrestris | A spiny vine | Tested repeatedly and largely negative for testosterone |
| Epimedium (horny goat weed) | A flowering plant; marker compound icariin | Cell culture and animal work at the PDE-5 target; no human dose established |
| L-arginine and L-citrulline | Amino acids | Well-mapped nitric-oxide pharmacology, at gram amounts |
| Muira puama, catuaba, damiana | Traditional South American tonics | Tradition, chemistry and rodent work; almost no controlled human trials |
| Green tea extract | Concentrated catechins | Randomised trials near 400 mg a day, mostly for blood pressure and lipids |
| Caffeine | A stimulant | One of the best-studied compounds in the food supply |
| Zinc and boron | Minerals | Real deficiency correction; weak evidence for supplementation in the replete |
Ordered roughly by how much human evidence exists rather than by how often the name appears on a label.
The uneven distribution in that third column is the whole story of this aisle. A systematic review of the ingredients in the best-selling products scored them against the published record and found that the names with the strongest reputations were frequently not the names with the strongest evidence, and a 2026 meta-analysis of randomised trials of herbal supplements in this indication reached a compatible conclusion.
Why so many labels here declare one blend figure
A proprietary blend declares a group of ingredients under a single weight instead of listing each amount. It is legal, it is normal, and it has two real purposes and one convenient side effect.
The real purposes are competitive. A formula that publishes nine exact amounts can be copied in an afternoon, and a manufacturer that adjusts its ratios between runs would otherwise have to reprint its labels. Both are legitimate.
The side effect is that a reader cannot tell whether an ingredient is present at a studied amount or at a pinch. On a blend of nine names, the only certainty is that no single one exceeds the total, and the average share is the total divided by nine. That arithmetic is doable by anybody and it is rarely done.
The useful habit is to read the blend total first and the ingredient list second. A long list under a small total is a shorter list than it looks.
The safety questions specific to this aisle
Two of them come from the ingredients and one comes from the market. The first ingredient question is epimedium: icariin acts at the same enzyme as prescription erectile-dysfunction tablets, which a review of plant PDE-5 inhibitors sets out, and MedlinePlus lists the interactions with nitrates and with blood-pressure medicines that follow from it.
The second is the liver. Ashwagandha appears in a case series drawn from two national registries and concentrated green tea extract in a US Pharmacopeia review, both at amounts far above what a multi-ingredient blend typically supplies, and both worth knowing if you already take something demanding of the liver.
The market question is the serious one. Products bought off the shelf in this category have been found to contain undeclared synthetic erectile-dysfunction compounds, the analytical literature on those analogues runs to reviews rather than case reports, and the FDA maintains a standing public list of the products it has found them in. That is a channel problem rather than a formula problem, and it is why a named seller with a lot number is worth what it is worth.
What actually moves the outcomes this aisle sells
This is the section a category guide owes its reader and most of them skip. Four things have better evidence behind them than anything on this shelf, and all four are free.
Sleep is the largest. Blood pressure control is the second, and it cuts both ways, because several medicines that treat it are also the ones that interact with epimedium. Alcohol is the third. Movement, in the ordinary walking sense, is the fourth.
None of that makes a supplement pointless. It means a supplement is the smallest lever in the set, and a reader who knows that will judge an 82 mg blend more calmly than one who does not. The NIH fact sheet on supplements for performance makes the same point about its own category and is worth ten minutes.
The practical version: if you are going to try something on this shelf, change one thing at a time and give it sixty days, so that whatever you conclude is about the bottle rather than about the month.
A short glossary for this aisle
| Term | What it means on a label here |
|---|---|
| Proprietary blend | A group of ingredients declared under one weight |
| Extract ratio | How much raw plant was reduced to make the extract; a 4:1 extract is four parts plant to one part powder |
| Dry-powder equivalent | The raw-plant weight an extract is said to correspond to |
| Standardised extract | An extract adjusted to contain a stated percentage of a marker compound; worth more than an unqualified extract name |
| Marker compound | The molecule used to measure an extract, such as icariin in epimedium |
| Structure and function claim | A statement about supporting a normal function, which is what a supplement may say |
| Daily value | The reference intake a percentage is calculated against; a dagger means none has been established |
| GMP | Good Manufacturing Practice: a statement about the facility |
| Adulteration | The presence of something undeclared, which in this aisle usually means a prescription compound |
Nothing in this glossary is specific to one brand. It applies to every label on the shelf.
Two of those are worth learning properly. Standardised extract is the phrase that separates a serious label from a casual one, because it commits the manufacturer to a measurable quantity of something. And dry-powder equivalent is the line that makes a small blend total look larger, which is fair when it is printed and misleading when it is implied.
Sources for this guide
Everything this guide links to, in one list.
- Björnsson HK, Björnsson ES, Avula B, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825-829. PMID 31991029. https://pubmed.ncbi.nlm.nih.gov/31991029/
- Oketch-Rabah HA, Roe AL, Rider CV, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep. 2020;7:386-402. PMID 32140423. https://pubmed.ncbi.nlm.nih.gov/32140423/
- Anand Ganapathy A, Hari Priya VM, Kumaran A. Medicinal plants as a potential source of Phosphodiesterase-5 inhibitors: A review. J Ethnopharmacol. 2021;267:113536. PMID 33137431. https://pubmed.ncbi.nlm.nih.gov/33137431/
- MedlinePlus, U.S. National Library of Medicine. Epimedium (horny goat weed). https://medlineplus.gov/druginfo/natural/699.html
- Kuchakulla M, Narasimman M, Soni Y, et al. A systematic review and evidence-based analysis of ingredients in popular male testosterone and erectile dysfunction supplements. Int J Impot Res. 2021;33(3):311-317. PMID 32358510. https://pubmed.ncbi.nlm.nih.gov/32358510/
- Ho CY, Hsu CH, Chien TJ. Herbal dietary supplements for erectile dysfunction: A systematic review and meta-analysis of randomized-controlled trials. J Tradit Complement Med. 2026;16(1):109-120. PMID 41696741. https://pubmed.ncbi.nlm.nih.gov/41696741/
- Kee CL, Ge X, Gilard V, et al. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements. J Pharm Biomed Anal. 2018;147:250-277. PMID 28903860. https://pubmed.ncbi.nlm.nih.gov/28903860/
- Campbell N, Clark JP, Stecher VJ, et al. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors. J Sex Med. 2013;10(7):1842-9. PMID 23634714. https://pubmed.ncbi.nlm.nih.gov/23634714/
- U.S. Food and Drug Administration. Sexual Enhancement and Energy Product Notifications. https://www.fda.gov/drugs/medication-health-fraud-notifications/sexual-enhancement-and-energy-product-notifications
- National Institutes of Health, Office of Dietary Supplements. Dietary supplements for exercise and athletic performance: fact sheet for health professionals. https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/
Order JellyFil knowing what the aisle is made of
Nine extracts, one blend figure, and a guide written to be used against anything else on the shelf.
Two bottles $158 · six bottles $294 · 60-day money-back guarantee
Order JellyFil From This ShopLot JEL-26/JE-2310 · one a day, 30 to a bottle · ships from the United States
